September 1, 2025

Glaukos Corporation (GKOS) Stock Analysis: A Healthcare Innovator with 27.8% Potential Upside

Investors looking for exposure in the healthcare sector, particularly in cutting-edge medical devices, may find Glaukos Corporation (NYSE: GKOS) an intriguing option. Known for its innovative therapies targeting glaucoma, corneal..

Humana Inc. (HUM) Stock Analysis: Is the Current Price Offering a Strategic Investment Opportunity?

For investors eyeing opportunities in the healthcare sector, Humana Inc. (NYSE: HUM) presents a fascinating case. As a leading provider of medical and specialty insurance products in the U.S., Humana..

Jazz Pharmaceuticals plc (JAZZ) Stock Analysis: A 46% Upside Potential with Strong Buy Ratings

Jazz Pharmaceuticals plc (NASDAQ: JAZZ), a prominent player in the biotechnology sector, is capturing investor attention with its robust portfolio and promising upside potential. Based in Dublin, Ireland, and with..

Abbott Laboratories (ABT) Stock Analysis: Steady Growth and a 7.41% Potential Upside

Abbott Laboratories (NYSE: ABT), a prominent player in the healthcare sector, continues to capture the attention of investors with its robust market performance and diversified product portfolio. With a market..

Tenet Healthcare Corporation (THC): Investor Outlook Highlights 7.16% Potential Upside and Strong Buy Ratings

Tenet Healthcare Corporation (NYSE: THC) is firmly positioned in the healthcare sector, specifically within the medical care facilities industry, and it has carved out a significant market presence in the..

BeOne Medicines Ltd. (ONC) Stock Analysis: A Biotech Powerhouse with 16.42% Potential Upside

For investors keeping a keen eye on the biotechnology sector, BeOne Medicines Ltd. (ONC) emerges as a compelling candidate. This Swiss-based oncology company, with a significant market cap of $35.55..

Fresenius Medical Care AG (FMS) Stock Analysis: Exploring 18% Potential Upside in Healthcare Sector

Fresenius Medical Care AG (NYSE: FMS) is a prominent name in the healthcare sector, specifically in the medical care facilities industry. With a market capitalization of $15.08 billion, this German-based..

Regencell Bioscience Holdings L (RGC) Stock Analysis: Navigating the Volatility with Strategic Insights

Investors with a keen eye on the healthcare sector, particularly those interested in niche markets like Traditional Chinese Medicine (TCM), may find Regencell Bioscience Holdings L (RGC) a compelling, albeit..

Natera, Inc. (NTRA) Stock Analysis: A Diagnostic Powerhouse with a 17.56% Potential Upside

Natera, Inc. (NTRA), a prominent player in the healthcare sector, has carved a niche for itself in the diagnostics and research industry. Headquartered in Austin, Texas, Natera is renowned for..

The Ensign Group, Inc. (ENSG) Stock Analysis: Navigating a 0.71% Upside with Robust Revenue Growth

The Ensign Group, Inc. (NASDAQ: ENSG), a key player in the healthcare sector, is catching the attention of investors with its robust performance metrics and promising growth trajectory. Specializing in..

Penumbra, Inc. (PEN) Stock Analysis: 14% Potential Upside as Healthcare Innovator Gains Traction

Penumbra, Inc. (NYSE: PEN), a prominent player in the healthcare sector specializing in medical devices, stands out with a market capitalization of $10.63 billion. The company, headquartered in Alameda, California,..

Mettler-Toledo International, Inc. (MTD) Stock Analysis: Navigating a Stable Path with Limited Upside Potential

Investors seeking exposure to the healthcare sector through a player in the diagnostics and research industry may find Mettler-Toledo International, Inc. (NYSE: MTD) an intriguing option. As a provider of..

Walgreens Boots Alliance (WBA) Stock Analysis: Navigating a High Dividend Yield Amidst Challenging Metrics

For investors with an eye on the healthcare sector, Walgreens Boots Alliance, Inc. (NASDAQ: WBA) presents a compelling if complex opportunity. As a leading player in the pharmaceutical retail industry,..

Charles River Laboratories (CRL) Stock Analysis: Healthcare Innovator with a 5.36% Upside

Charles River Laboratories International, Inc. (NYSE: CRL), a prominent name in the healthcare sector’s diagnostics and research industry, continues to capture investor attention. With a market cap of $8.04 billion,..

DexCom, Inc. (DXCM) Stock Analysis: A 35% Potential Upside Beckons Investors

DexCom, Inc. (NASDAQ: DXCM) stands as a beacon of innovation within the healthcare sector, specifically in the medical devices industry. Known for its pioneering work in continuous glucose monitoring (CGM)..

United Therapeutics Corporation (UTHR) Stock Analysis: A Deep Dive into 24.87% Potential Upside

United Therapeutics Corporation (NASDAQ: UTHR) stands out as a promising player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. As the company continues to address..

Merck & Company, Inc. (MRK) Stock Analysis: Exploring 19.37% Potential Upside for Investors

Merck & Company, Inc. (NYSE: MRK) continues to be a formidable presence in the healthcare sector, boasting a market capitalization of $210.11 billion. As a leading player in the drug..

Pfizer, Inc. (PFE) Stock Analysis: Exploring a 16% Potential Upside Amid Global Biopharmaceutical Expansion

Pfizer, Inc. (NYSE: PFE), a titan in the healthcare sector, commands significant attention with its expansive portfolio in the drug manufacturing industry. Headquartered in the bustling city of New York,..

IDEXX Laboratories, Inc. (IDXX) Stock Analysis: Exploring a 7.42% Potential Upside and Robust Revenue Growth

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a leading player in the healthcare sector specializing in diagnostics and research, is capturing investor attention with its impressive market cap of $51.77 billion and..

Labcorp Holdings Inc. (LH) Stock Analysis: Solid Growth and Potential Upside Make It a Compelling Healthcare Play

Labcorp Holdings Inc. (NYSE: LH), a prominent player in the healthcare sector, stands out in the Diagnostics & Research industry with a market capitalization of $23.1 billion. As the company..

Search

Funds

September 1, 2025

Search

Funds

September 1, 2025

FTSE 100

Funds